Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
6.–10. rezultāts no 60.
369. lappuse
... Ampicillin Diluent ( solution num- Initial solvent ber as listed in § 436.101 ( a ) ) Final concentra- tion units or milli- grams per milli- liter Distilled water 1.0 mg Storage time under refrigera- tion 7 days Dimethylsulfoxide 1 mg ...
... Ampicillin Diluent ( solution num- Initial solvent ber as listed in § 436.101 ( a ) ) Final concentra- tion units or milli- grams per milli- liter Distilled water 1.0 mg Storage time under refrigera- tion 7 days Dimethylsulfoxide 1 mg ...
380. lappuse
... Ampicillin Cephalexin Cephaloridine Cephalothin Cephapirin Cloxacillin Cyclacillin Dicloxacillin Methicillin ... Ampicillin Ampicillin sodium Ampicillin trihydrate Antibiotic None ...... do ...... do ...... do Diluent ( solution num- ber ...
... Ampicillin Cephalexin Cephaloridine Cephalothin Cephapirin Cloxacillin Cyclacillin Dicloxacillin Methicillin ... Ampicillin Ampicillin sodium Ampicillin trihydrate Antibiotic None ...... do ...... do ...... do Diluent ( solution num- ber ...
381. lappuse
... ampicillin activity per milliliter of sample . The ampicillin working standard is used for the assay of bacampicillin hydrochloride . A x Potency ( in units or micrograms per milliliter. Antibiotic Diluent ( solution num- ber as listed ...
... ampicillin activity per milliliter of sample . The ampicillin working standard is used for the assay of bacampicillin hydrochloride . A x Potency ( in units or micrograms per milliliter. Antibiotic Diluent ( solution num- ber as listed ...
382. lappuse
... - centration and then proceed as directed in paragraph ( d ) of this section . Antibiotic Amoxicillin trihydrate Ampicillin Ampicillin sodium Ampicillin trihydrate Bacampicillin hydrochloride. 382 § 436.205 21 CFR Ch . I ( 4-1-98 Edition )
... - centration and then proceed as directed in paragraph ( d ) of this section . Antibiotic Amoxicillin trihydrate Ampicillin Ampicillin sodium Ampicillin trihydrate Bacampicillin hydrochloride. 382 § 436.205 21 CFR Ch . I ( 4-1-98 Edition )
383. lappuse
... Ampicillin Ampicillin sodium Ampicillin trihydrate Bacampicillin hydrochloride Cefazolin sodium Cephaloridine ..... .... Cloxacillin sodium monohydrate . Cyclacillin Diluent ( solution number as listed in § 436.101 ( a ) ) Final con ...
... Ampicillin Ampicillin sodium Ampicillin trihydrate Bacampicillin hydrochloride Cefazolin sodium Cephaloridine ..... .... Cloxacillin sodium monohydrate . Cyclacillin Diluent ( solution number as listed in § 436.101 ( a ) ) Final con ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning